戻る Agenda
IMEDS: A Collaboration Based on the FDA's Sentinel Initiative
Session Chair(s)
June Wasser, MA
Executive Director
Reagan-Udall Foundation For the FDA, United States
This forum will educate industry on how, when, and why, utilizing IMEDS may be helpful to answering drug safety and other types of pharmacovigilance research questions.
Learning Objective : Explain the IMEDS program and the role of the Reagan-Udall Foundation for the FDA; Distinguish the IMEDS database from other safety study databases; Illustrate the purpose and uses of the IMEDS program.
Speaker(s)
Panelist
Cheryl Walraven, PHD
Aetna, United States
Director, Informatics
IMEDS Analytic Center: Supporting the IMEDS Research Portfolio
Jeffrey Brown, PHD, MA
Harvard Pilgrim Health Care Institute/Harvard Medical School, United States
Associate Professor, Department of Population Medicine
Panelist
Claudia Salinas, PHD
Eli Lilly and Company, United States
Senior Director, GPS Pharmacoepidemiology